CAR-T In Vitro Cytotoxicity: Multi-Assay Comparison

Multiparametric Analysis of CAR-T Cell Activity

Accurately assessing in vitro cytotoxicity is essential to optimize the efficacy and development of CAR-T cell therapies. In this study presented by Pharmaron at the 28th ASGCT Annual Meeting, the cytotoxic activity of CD19-targeting CAR-T cells was evaluated against Raji-Luc cancer cells using three distinct assay platforms: flow cytometry, Maestro Z, and CLARIOstar.

These platforms offer complementary perspectives on CAR-T cell potency, enabling robust decision-making across early-stage research and translational development.

Three Assays, One Goal: Defining CAR-T Cytolytic Performance

CAR-T cells were generated via lentiviral transduction and co-cultured with Raji-Luc cells at different effector-to-target (E:T) ratios (1:1 and 5:1). Key findings include:

Flow Cytometry: Enabled detailed analysis of CAR-T cell activation markers (e.g., CD69) and target cell viability using 7-AAD and CD20 staining..
Maestro Z: Provided real-time, label-free measurement of cell impedance as a marker for cytolysis over 48 hours.
CLARIOstar: Quantified residual tumor cell viability using luciferase signal; ideal for EC₅₀ determination.

Each method revealed nuanced insights into cytotoxic function, allowing for cross-platform validation of CAR-T potency. Maestro Z proved especially useful for dynamic monitoring, while CLARIOstar enabled precise potency quantification.

Translational Impact

This assay comparison supports fit-for-purpose cytotoxicity screening in CAR-T development pipelines, reducing experimental variability and aligning analytical choices with project goals. Key benefits include:

Early identification of functional CAR constructs
EC₅₀ estimation for potency ranking
Real-time dynamic killing profiles
Flexible selection of assays for clinical translation

Explore in-depth assay data, flow gating strategies, and platform comparisons. Download the full poster presented at ASGCT 2025 to streamline your CAR-T screening workflows.

Name(Required)

First Last

Company Name(Required)

Job Title(Required)

Country(Required)

State(Required)

Message

Email(Required)

This field is hidden when viewing the form

Lead Source(Required)

By completing and submitting this form, you acknowledge that you have read and understood our Privacy Policy, and you consent to the collection and processing of your personal data by Pharmaron for the purpose of responding to your inquiry. You also agree to be contacted by Pharmaron regarding relevant services and updates. You may withdraw your consent at any time.